Vor Biopharma And Metagenomi To Collaborate On Engineered Hematopoietic Stem Cell Therapies
Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, and Metagenomi, a gene editing company discovering breakthrough systems for curing genetic disease, today announced that Vor will evaluate the potential use of Metagenomi’s gene editing technology to develop engineered hematopoietic stem cell-based therapies for the treatment of blood cancers, such as acute myeloid leukemia. “Cancer patients deserve therapies with strong effects on cancer cells and minimal effects on all other cells,” said Tirtha Chakraborty, Ph.D., Vor’s VP and Head of Research. “Our new partnership with Metagenomi will help us achieve this goal by engineering hematopoietic stem cells using precise yet flexible gene editing – thereby ensuring that targeted therapies can live up to their name." The collaboration is non-exclusive and applies to pre-clinical research only. Further terms of the agreement are not being disclosed. “This partnership unites two transformative technologies – our proprietary gene editing enzymes, and Vor’s platform for engineering hematopoietic stem cells such that they are inherently treatment-resistant,” said Brian C. Thomas, Metagenomi’s CEO and co-founder. “We are excited to be working together to bring both of these cutting-edge approaches into the clinic.”

Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!